Wayne Winegarden is a senior fellow in business and economics at the Pacific Research Institute and director of PRI’s Center for Medical Economics and Innovation.
Opinion
Biosimilars offer NC rare opportunity to save millions without cutting care
A new analysis estimates that NC could save between $31.0 million and $62.8 million annually simply by giving greater priority to lower-cost biosimilars when they are already available.
